Understanding the 18.10% Volatility Levels of BeyondSpring Inc’s (BYSI) Stock in the Past 30 Days

The stock of BeyondSpring Inc (BYSI) has gone down by -5.48% for the week, with a 118.67% rise in the past month and a 264.44% rise in the past quarter. The volatility ratio for the week is 10.13%, and the volatility levels for the past 30 days are 18.10% for BYSI. The simple moving average for the past 20 days is 6.34% for BYSI’s stock, with a 173.04% simple moving average for the past 200 days.

Is It Worth Investing in BeyondSpring Inc (NASDAQ: BYSI) Right Now?

Company’s 36-month beta value is 0.17.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The public float for BYSI is 23.73M, and currently, short sellers hold a 9.90% ratio of that floaft. The average trading volume of BYSI on April 03, 2024 was 210.48K shares.

BYSI) stock’s latest price update

The stock of BeyondSpring Inc (NASDAQ: BYSI) has decreased by -8.89 when compared to last closing price of 3.60.Despite this, the company has seen a loss of -5.48% in its stock price over the last five trading days. GlobeNewsWire reported 2023-09-27 that NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative therapies to improve clinical outcomes for patients with high unmet medical needs, today announced the presentation of a poster at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting, taking place on November 3 through 5 in San Diego, CA.

Analysts’ Opinion of BYSI

Many brokerage firms have already submitted their reports for BYSI stocks, with Jefferies repeating the rating for BYSI by listing it as a “Hold.” The predicted price for BYSI in the upcoming period, according to Jefferies is $5 based on the research report published on December 02, 2021 of the previous year 2021.

BofA Securities, on the other hand, stated in their research note that they expect to see BYSI reach a price target of $5, previously predicting the price at $45. The rating they have provided for BYSI stocks is “Underperform” according to the report published on December 02nd, 2021.

BYSI Trading at 71.53% from the 50-Day Moving Average

After a stumble in the market that brought BYSI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.00% of loss for the given period.

Volatility was left at 18.10%, however, over the last 30 days, the volatility rate increased by 10.13%, as shares surge +100.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +272.73% upper at present.

During the last 5 trading sessions, BYSI fell by -5.48%, which changed the moving average for the period of 200-days by +190.27% in comparison to the 20-day moving average, which settled at $3.17. In addition, BeyondSpring Inc saw 264.44% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for BYSI

Current profitability levels for the company are sitting at:

  • -24.34 for the present operating margin
  • 1.0 for the gross margin

The net margin for BeyondSpring Inc stands at -21.91.

When we switch over and look at the enterprise to sales, we see a ratio of 379.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.78.


In a nutshell, BeyondSpring Inc (BYSI) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts